Delfina Care, a San Francisco, CA-based healthcare technology company, raised $17M in Series A funding.
The round was led by USVP, with participation from new investors ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund and existing investors including Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton’s Metrodora Ventures.
The company intends to use the funds to support national expansion, further innovation of its AI technology, and continued partnerships with diverse healthcare providers.
Led by Senan Ebrahim, MD, PhD, CEO and Founder, Delfina provides an AI-powered maternal health platform that combines predictive analytics, tailored interventions, and closed-loop connection (through data) between the patient and their primary prenatal care provider to improve outcomes for moms and babies. Partners have observed reductions in preterm births, NICU admissions, hypertensive disorders, and gestational diabetes, the leading causes of preterm births, maternal morbidity, and mortality.
FinSMEs
29/01/2025